TD Securities analyst Tim James lowered the firm’s price target on Andlauer Healthcare (ANDHF) to C$53 from C$54 and keeps a Buy rating on the shares.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ANDHF:
- Andlauer Healthcare Group Reports Stable 2024 Earnings
- Andlauer Healthcare Group Reports Stable 2024 Financial Results Amid Market Challenges
- Andlauer Healthcare price target raised to C$52 from C$50 at Stifel
- Andlauer Healthcare Group, Inc. (ANDHF) Q4 Earnings Cheat Sheet
- Andlauer Healthcare price target raised to C$49 from C$45 at National Bank